Chou-Yuan Ko
Overview
Explore the profile of Chou-Yuan Ko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin H, Lee Y, Chang C, Kuo C, Ho H, Wu C, et al.
Ann Med
. 2025 Jan;
57(1):2447405.
PMID: 39829258
Background: Nurses on the frontlines of the pandemic have increased workloads, burnout, and virus exposure, leading to mental health challenges and a lack of resources for patient care. Mental health...
2.
Wu Y, Chiao C, Chuang P, Hsieh C, Ko C, Ko C, et al.
Int J Med Sci
. 2024 Sep;
21(12):2348-2364.
PMID: 39310264
Recent advancements have elucidated the multifaceted roles of the Schlafen (SLFN) family, including SLFN5, SLFN11, SLFN12, SLFN13, and SLFN14, which are implicated in immunological responses. However, little is known about...
3.
Singh M, Alka , Shukla P, Wen Z, Ko C, Vinayagam R
Curr Drug Deliv
. 2024 Jan;
PMID: 38204256
Background: Gefitinib (GFN) is an Epithelial Growth Factor Receptor (EGFR) inhibitor, and Food and Drug Administration (FDA) has approved medication to treat lung cancer. However, this investigation aimed to produce...
4.
Hu T, Wu J, Huang S, Chu T, Han A, Shih T, et al.
J Biol Chem
. 2023 Oct;
299(11):105335.
PMID: 37827291
Hepatoma-derived growth factor (HDGF) overexpression and uncontrolled reactive oxygen species (ROS) accumulation are involved in malignant transformation and poor prognosis in various types of cancer. However, the interplay between HDGF...
5.
Tsai Y, Yu M, Ko C, Hsin Y, Tsai Q, Huang C
BMJ Open
. 2023 Jun;
13(6):e070490.
PMID: 37286314
Objective: Hepatitis C is an important risk factor for cirrhosis and liver cancer in the Taiwanese population. Domestic prisons reported a higher rate of hepatitis C infection than the national...
6.
Tzou S, Chen I, Chu T, Chian D, Wang F, Lee Y, et al.
Med Sci Monit
. 2023 May;
29:e939949.
PMID: 37183387
BACKGROUND Self-injection locking (SIL) radar uses continuous-wave radar and an injection-locked oscillator-based frequency discriminator that receives and demodulates radar signals remotely to monitor vital signs. This study aimed to compare...
7.
Shih P, Chen H, Hsu C, Lin C, Ko C, Hsueh C, et al.
Environ Pollut
. 2023 Mar;
327:121476.
PMID: 36997141
Plasticizers are considered as environmental pollution released from medical devices and increased potential oncogenic risks in clinical therapy. Our previous studies have shown that long-term exposure to di-ethylhexyl phthalate (DEHP)/mono-ethylhexyl...
8.
Huang S, Huang C, Ko C, Huang C, Liu C, Lee Y, et al.
Gene
. 2023 Mar;
865:147331.
PMID: 36871674
Slow skeletal muscle troponin T (TNNT1) as a poor prognostic indicator is upregulated in colon and breast cancers. However, the role of TNNT1 in the disease prognosis and biological functions...
9.
Chu T, Ko C, Tai P, Chang Y, Huang C, Wu T, et al.
J Biol Chem
. 2022 Sep;
298(10):102442.
PMID: 36055405
Leukocyte cell-derived chemotaxin 2 (LECT2) acts as a tumor suppressor in hepatocellular carcinoma (HCC). However, the antineoplastic mechanism of LECT2, especially its influence on hepatic cancer stem cells (CSCs), remains...
10.
Lee M, Lee Y, Huang S, Chang C, Ko C, Lee W, et al.
Genes (Basel)
. 2022 Apr;
13(4).
PMID: 35456435
Clear cell renal cell carcinoma (ccRCC) is the most common RCC subtype with a high mortality. It has been reported that delta-like 1 homologue (DLK1) participates in the tumor microenvironmental...